Mondaq All Regions: Food, Drugs, Healthcare, Life Sciences
Corrs Chambers Westgarth
How can we ensure that our continued adoption of technology in the health industry grows sustainably and ethically?
Singh & Associates
Haemophilia A is an inherited bleeding disorder caused by lack of a clotting protein called factor VIII and mainly affects males.
Singh & Associates
On January 15, 2018, the World Health Organization's (WHO) Global Tuberculosis Programme has released a Position Statement on the use of delamanid in treatment of multidrug-resistant tuberculosis (MDR-TB).
Singh & Associates
On January 29, 2018 World Health Organization (WHO) released the surveillance data of new "Global Antimicrobial Surveillance System (GLASS)" on antibiotic resistance.
Singh & Associates
The National Pharmaceutical Pricing Authority, is an executive body under the Drugs (Prices Control) Order, 2013 under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India.
Singh & Associates
The United States Food and Drug Administration (USFDA) approved more Abbreviated New Drug Application (ANDA) in 2017 than any other year, according to its latest FY 2017 activities report.
Singh & Associates
On January 19, 2018, the CDSCO has published clarification regarding issuance of NOC for issuing Form 29 License used to manufacture drugs for the purposes of examination, test or analysis of biological products (Vaccines 86 r-DNA products).
Gowling WLG
On December 28, 2017, President Putin signed the Law on Amendments to the Law on Circulation of Medicines.
Wright Hassall LLP
The financial predicaments of some of the largest UK care providers have been well documented. In the recent past, the collapse of Southern Cross ...
Foley & Lardner
Hospital-based telemedicine services continue to rapidly expand across the country, allowing providers to deliver care to rural areas and better allocate the staffing and availability of specialist physicians such as neurologists and emergency medicine.
McDermott Will & Emery
Penrose v. Buffalo Trace Distillery, E.D. Mo. 4:17-cv-00294-HEA, involves the labeling of Old Charter bourbon.
Seyfarth Shaw LLP
Welcome back to The Week in Weed, your Friday look at what's happening in the world of legalized marijuana.
McDermott Will & Emery
In a two-page memorandum, the US Department of Justice (DOJ) announced a broad policy statement prohibiting the use of agency guidance documents as the basis for proving legal violations in civil ...
Day Pitney LLP
A February 13 article in Bloomberg BNA's Health IT Law & Industry Report and other publications, "Trump Budget Takes an Ax to Health-Care IT Agency," ...
Archer & Greiner P.C.
We are sending this alert to direct your attention to the fact that a little known regulatory deadline is rapidly approaching for all New Jersey licensed health care facilities.
Sheppard Mullin Richter & Hampton
On Friday, February 9, 2018, President Trump signed the Bipartisan Budget Act of 2018, a two-year budget which, in significant part, made substantial revisions to Medicare, including the Medicare Advantage (MA) program.
Foley Hoag LLP
On March 21 and 22, two of this blog's authors will be presenting on two Medicaid topics at the American Health Lawyer's Association (AHLA) ...
Jones Day
The Bipartisan Budget Act of 2018, signed into law on February 9, 2018, imposes changes on health care fraud and abuse laws that appear to reflect Congress's desire to reduce the draconian threat of strict liability under the Stark Law, while increasing penalties applicable to intent-based violations of the Anti-Kickback Statute ("AKS") and the Civil Monetary Penalties Law ("CMP Law").
On February 12, 2018, the Trump administration released its Fiscal Year (FY) 2019 budget request.
Reed Smith
This should not be controversial. It has been settled since Hahn v. Richter, 673 A.2d 888 (Pa. 1996) that in Pennsylvania prescription drugs are exempt from strict liability.
Most Popular Recent Articles
Borden Ladner Gervais LLP
Our annual thought leadership report is now available to download.
Norton Rose Fulbright Australia
Businesses in food and agriculture industries should be particularly alive to the risk of slavery in their supply chains.
Holman Webb
Future action for non-compliance with the ACL in the marketing of therapeutic goods may result in much higher penalties.
Carroll & O'Dea
The appeal addressed how the trial judge could properly choose between competing expert opinions on mental harm.
Holman Webb
A genomic profile may help a doctor make personalised health decisions, but also raises a number of ethical challenges.
Norton Rose Fulbright Australia
The article considers the responses to some of the key recommendations and potential implications of these responses.
Holman Webb
The Appeal decision confirms the need to understand medical malpractice and civil liability policy terms and conditions.
Carroll & O'Dea
This article focuses on some information provision issues addressed in the new ethical guidelines on the use of ART.
Morgan Lewis
Amgen paints a different picture as to the bad actor during the parties' negotiations pursuant to the Biologics Price Competition and Innovation Act.
Carroll & O'Dea
The balancing exercise between confidentiality and the patient's potential risk to the community has become no easier.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Font Size:
Mondaq on Twitter